On 22 and 23 November, Fortis Memorial Research Institute, Gurugram (Fortis Gurugram) hosted HemeNext 1.0, a pioneering national conference exploring how genomics, artificial intelligence, robotics and advanced cell therapies are reshaping haematology and infectious disease care across India.
With the nation facing rising cases of blood cancers, immune disorders and complex infections, the two-day event emphasised the growing importance of early diagnosis and personalised, data-driven treatment. More than 150 clinicians attended in person, while over 1,700 participants joined online, including haematologists, infectious disease specialists, bone marrow transplant physicians, CAR-T innovators and young clinicians.
A major highlight was India’s first humanoid healthcare host, Hembot. Powered by NVIDIA Jetson Orin, the robot greeted delegates, guided them to sessions, engaged in discussions and even joined the gala evening. Its presence demonstrated how future hospitals may use humanoid robotics for patient navigation, clinical support, monitoring assistance and uplifting the overall care experience.
The conference’s scientific discussions centred on the growing impact of genomics in diagnosing and treating leukaemia, lymphoma, bone marrow failure syndromes and inherited blood disorders. Experts highlighted advances such as next-generation sequencing for deep cancer profiling, mutation analysis for sharper diagnoses, relapse prediction through genomic algorithms and genomics-based donor matching that improves transplant safety and success.
HemeNext 1.0 also showcased how AI, robotics and next-generation therapies like CAR-T are enabling faster diagnoses, more accurate testing, safer bone marrow transplants and better survival outcomes through personalised treatment pathways. Real-world case discussions and mentorship sessions reinforced how these innovations are improving everyday clinical decisions.
Leaders from Fortis Gurugram shared their commitment to building one of India’s strongest precision-haematology ecosystems, uniting genomics, advanced diagnostics, cell therapies and AI-driven tools to provide comprehensive care for adults and children alike.
HemeNext 1.0 reflects Fortis Gurugram’s vision for compassionate, technology-enabled haematology care that brings renewed hope to patients across India.
Related Stories
IHH Singapore and Medistra Hospital Sign MoU to Strengthen Liver Disease Care in the Region
IHH Healthcare Singapore and Medistra Hospital signed a Memorandum of Understanding (MoU) on 22 January 2026, marking a significant step forward in advancing liver disease services and strengthening healthcare quality across the region.
Pantai Hospital Kuala Lumpur Performs Combined Airway and Heart Surgery on One-Year-Old
A multidisciplinary team at Pantai Hospital Kuala Lumpur has successfully performed a combined surgery to repair both the airway and heart of a one-year-old child, addressing two life-threatening conditions in a single operation.
Friends of Fortis Programme Highlights Robotic Knee Replacement Outcomes in Amritsar
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
